Tab newceta 10mg

Reading File
Finding Sources
Searching PubMed

cetirizine

Searching the Web

Newceta 10 mg tablet composition

If you mean Newcita 10 mg, it contains escitalopram 10 mg, a prescription antidepressant (SSRI) used for depression and anxiety.
  • Take only as prescribed, usually once daily.
  • Common effects: nausea, headache, sleepiness or insomnia, dizziness, dry mouth, and sexual side effects.
  • Do not stop it suddenly, as withdrawal symptoms can occur.
  • Seek urgent help for suicidal thoughts, severe agitation, allergic reaction, or signs of serotonin excess such as fever, confusion, severe tremor, or muscle stiffness.
  • Avoid alcohol and tell your prescriber about other antidepressants, tramadol, migraine medicines, or blood thinners.
The name you wrote, “Newceta,” may be a spelling variation or a different product. Please share a photo or the exact composition printed on the strip to confirm.

So what should i do if i want to stop

Reading File
Finding Sources
Searching PubMed

antidepressant discontinuation tapering

Searching the Web

NICE antidepressants stopping tapering guidance escitalopram withdrawal symptoms

Do not stop Newcita 10 mg (escitalopram) suddenly unless a clinician tells you to because of a serious reaction.
  1. Contact the doctor who prescribed it and ask for a tapering plan. Antidepressants are usually reduced in stages, with follow-up for withdrawal symptoms and return of anxiety/depression, as NICE advises.
  2. Do not skip alternate days or cut tablets at random. The exact reduction depends on how long you have taken 10 mg, why it was prescribed, whether you have had withdrawal before, and whether your tablets can be safely split or a liquid form is available.
  3. If symptoms appear during dose reduction, such as dizziness, nausea, anxiety, insomnia, unusual dreams, low mood, irritability, or “electric-shock” sensations, contact your prescriber. The taper may need to be slowed or paused. NICE guidance notes symptoms can begin within days and can be severe after abrupt stopping.
  4. Get urgent help today if you have suicidal thoughts, feel unable to stay safe, severe agitation/confusion, or rapidly worsening depression or panic.
Please tell me:
  • how long you have been taking Newcita 10 mg,
  • whether it is for anxiety, depression, or another reason,
  • and whether you have already missed or stopped any doses.
Then I can explain what to discuss with your prescriber.

How long should my escitalopram taper usually take?

Reading File
Finding Sources
Searching PubMed

antidepressant tapering withdrawal

Searching the Web

Royal College Psychiatrists stopping antidepressants escitalopram taper 25% 50% guidance

For many people taking escitalopram 10 mg for only a few weeks, a clinician may use a taper over roughly 4 to 8 weeks, reducing the dose every 2 to 4 weeks if symptoms stay manageable.
If you have taken it for months or years, previously had withdrawal symptoms, are taking it for recurrent depression/anxiety, or feel unwell with reductions, tapering may need to take several months or longer. There is no single correct duration.
A general clinician-guided approach is to reduce the current dose stepwise, often by about 25% to 50%, wait 2 to 4 weeks, then reassess. Smaller reductions, such as 10% or 5%, may be used when someone is sensitive to withdrawal or at lower doses. NICE recommends stepwise reductions, commonly starting around 50% of the prior dose and using smaller reductions as doses get lower, with liquid medication if needed (NICE recommendations).
Do not take escitalopram on alternate days to taper. This causes fluctuating drug levels and can make withdrawal more likely.
If withdrawal symptoms occur, pause further reductions and contact your prescriber. Symptoms can include dizziness, nausea, anxiety, poor sleep, vivid dreams, low mood, irritability, or “electric shock” sensations. Severe anxiety, suicidal thoughts, or inability to stay safe needs urgent medical help.
Recent evidence reviews show withdrawal symptoms can vary substantially between individuals, supporting an individualized rather than fixed-speed taper (2025 systematic review).
This is a shared conversation. Sign in to Orris to start your own chat.